FDA Clarifies Trial Requirements for Gastroparesis Drugs

Clinical Trials Advisor
A A
Drugmakers developing treatments for diabetic and idiopathic gastroparesis should study those patient populations in separate trials, the FDA says.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00